ProShare Advisors’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-393
| Closed | -$62K | – | 2325 |
|
|
2021
Q4 | $62K | Buy |
393
+14
| +4% | +$2.21K | ﹤0.01% | 2261 |
|
|
2021
Q3 | $76K | Sell |
379
-101
| -21% | -$20.3K | ﹤0.01% | 1944 |
|
|
2021
Q2 | $123K | Buy |
480
+58
| +14% | +$14.9K | ﹤0.01% | 2262 |
|
|
2021
Q1 | $112K | Buy |
422
+29
| +7% | +$7.7K | ﹤0.01% | 2151 |
|
|
2020
Q4 | $145K | Buy |
+393
| New | +$145K | ﹤0.01% | 1927 |
|
|
2015
Q4 | – | Sell |
-41
| Closed | -$19K | – | 1728 |
|
|
2015
Q3 | $19K | Sell |
41
-1
| -2% | -$463 | ﹤0.01% | 1435 |
|
|
2015
Q2 | $24K | Hold |
42
| – | – | ﹤0.01% | 1642 |
|
|
2015
Q1 | $356K | Buy |
42
+8
| +24% | +$67.8K | ﹤0.01% | 1369 |
|
|
2014
Q4 | $301K | Buy |
+34
| New | +$301K | ﹤0.01% | 1511 |
|